SUPN vs. LSCC

Last updated Jun 4, 2026

SUPN (Supernus Pharmaceuticals, Inc.) and LSCC (Lattice Semiconductor Corporation) are both stocks. SUPN operates in Drug Manufacturers - Specialty & Generic (Healthcare), while LSCC operates in Semiconductors (Technology). Over the past 10 years, SUPN returned 8.47%/yr vs 38.58%/yr for LSCC. At a 0.22 correlation, their price movements are largely independent.

Performance

SUPN vs. LSCC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Supernus Pharmaceuticals, Inc. (SUPN) and Lattice Semiconductor Corporation (LSCC). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SUPN achieves a -11.40% return, which is significantly lower than LSCC's 110.11% return. Over the past 10 years, SUPN has underperformed LSCC with an annualized return of 8.47%, while LSCC has yielded a comparatively higher 38.58% annualized return.

SUPN

• 1D: -0.08%
• 1M: -9.45%
• YTD: -11.40%
• 6M: -1.62%
• 1Y: 36.63%
• 3Y*: 9.51%
• 5Y*: 8.06%
• 10Y*: 8.47%

LSCC

• 1D: 2.15%
• 1M: 23.12%
• YTD: 110.11%
• 6M: 105.78%
• 1Y: 232.26%
• 3Y*: 24.79%
• 5Y*: 23.81%
• 10Y*: 38.58%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SUPN vs. LSCC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SUPN Supernus Pharmaceuticals, Inc.	-11.40%	37.44%	24.95%	-18.87%	22.33%	15.90%	6.07%	-28.60%	-16.64%	57.82%
LSCC Lattice Semiconductor Corporation	110.11%	29.89%	-17.89%	6.33%	-15.81%	68.18%	139.39%	176.59%	19.72%	-21.47%

Correlation

The correlation between SUPN and LSCC is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.19
Correlation (3Y) Calculated over the trailing 3-year period	0.19
Correlation (5Y) Calculated over the trailing 5-year period	0.25
Correlation (10Y) Calculated over the trailing 10-year period	0.24
Correlation (All Time) Calculated using the full available price history since May 2, 2012	0.22

Fundamentals

Market Cap SUPN : $2.54B LSCC : $21.55B
EPS SUPN : -$0.51 LSCC : $0.14
PS Ratio SUPN : 3.23 LSCC : 37.16
PB Ratio SUPN : 2.36 LSCC : 29.11
Total Revenue (TTM) SUPN : $776.83M LSCC : $574.01M
Gross Profit (TTM) SUPN : $665.28M LSCC : $383.93M
EBITDA (TTM) SUPN : $78.83M LSCC : $65.23M

Return for Risk

SUPN vs. LSCC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SUPN

SUPN Risk / Return Rank: 69
SUPN Sharpe Ratio Rank: 73
SUPN Sortino Ratio Rank: 66
SUPN Omega Ratio Rank: 70
SUPN Calmar Ratio Rank: 71
SUPN Martin Ratio Rank: 68

LSCC

LSCC Risk / Return Rank: 97
LSCC Sharpe Ratio Rank: 98
LSCC Sortino Ratio Rank: 96
LSCC Omega Ratio Rank: 95
LSCC Calmar Ratio Rank: 98
LSCC Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SUPN vs. LSCC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Supernus Pharmaceuticals, Inc. (SUPN) and Lattice Semiconductor Corporation (LSCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SUPN	LSCC	Difference
Sharpe ratio Return per unit of total volatility	1.02	4.41	-3.39
Sortino ratio Return per unit of downside risk	1.51	4.46	-2.95
Omega ratio Gain probability vs. loss probability	1.22	1.58	-0.36
Calmar ratio Return relative to maximum drawdown	1.62	12.10	-10.48
Martin ratio Return relative to average drawdown	3.39	36.01	-32.61
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SUPN vs. LSCC - Sharpe Ratio Comparison

The current SUPN Sharpe Ratio is 1.02, which is lower than the LSCC Sharpe Ratio of 4.41. The chart below compares the historical Sharpe Ratios of SUPN and LSCC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SUPN	LSCC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.02	4.41	-3.39
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.23	0.44	-0.21
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.19	0.77	-0.57
Sharpe Ratio (All Time) Calculated using the full available price history	0.28	0.23	+0.05

Drawdowns

SUPN vs. LSCC - Drawdown Comparison

The maximum SUPN drawdown since its inception was -75.86%, smaller than the maximum LSCC drawdown of -97.34%. Use the drawdown chart below to compare losses from any high point for SUPN and LSCC.

Drawdown Indicators

	SUPN	LSCC	Difference
Max Drawdown Largest peak-to-trough decline	-75.86%	-97.34%	+21.48%
Max Drawdown (1Y) Largest decline over 1 year	-22.75%	-19.33%	-3.42%
Max Drawdown (3Y) Largest decline over 3 years	-36.16%	-61.09%	+24.93%
Max Drawdown (5Y) Largest decline over 5 years	-45.94%	-61.09%	+15.15%
Max Drawdown (10Y) Largest decline over 10 years	-75.86%	-61.09%	-14.77%
Current Drawdown Current decline from peak	-26.42%	0.00%	-26.42%
Average Drawdown Average peak-to-trough decline	-36.76%	-55.16%	+18.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.82%	6.48%	+4.34%

Volatility

SUPN vs. LSCC - Volatility Comparison

The current volatility for Supernus Pharmaceuticals, Inc. (SUPN) is 10.31%, while Lattice Semiconductor Corporation (LSCC) has a volatility of 16.53%. This indicates that SUPN experiences smaller price fluctuations and is considered to be less risky than LSCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SUPN	LSCC	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.31%	16.53%	-6.22%
Volatility (6M) Calculated over the trailing 6-month period	22.30%	40.54%	-18.24%
Volatility (1Y) Calculated over the trailing 1-year period	36.17%	53.16%	-16.99%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.23%	53.94%	-18.71%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	43.85%	50.46%	-6.61%

Dividends

SUPN vs. LSCC - Dividend Comparison

Neither SUPN nor LSCC has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

SUPN vs. LSCC - Profitability Comparison

The chart below illustrates the profitability comparison between Supernus Pharmaceuticals, Inc. and Lattice Semiconductor Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SUPN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Supernus Pharmaceuticals, Inc. reported a gross profit of 184.31M and revenue of 207.71M. Therefore, the gross margin over that period was 88.7%.

LSCC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lattice Semiconductor Corporation reported a gross profit of 117.63M and revenue of 170.90M. Therefore, the gross margin over that period was 68.8%.

SUPN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Supernus Pharmaceuticals, Inc. reported an operating income of -8.33M and revenue of 207.71M, resulting in an operating margin of -4.0%.

LSCC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lattice Semiconductor Corporation reported an operating income of 26.07M and revenue of 170.90M, resulting in an operating margin of 15.3%.

SUPN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Supernus Pharmaceuticals, Inc. reported a net income of -2.29M and revenue of 207.71M, resulting in a net margin of -1.1%.

LSCC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lattice Semiconductor Corporation reported a net income of 21.82M and revenue of 170.90M, resulting in a net margin of 12.8%.

Frequently Asked Questions

Can I hold both SUPN and LSCC in my portfolio?

SUPN and LSCC have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SUPN or LSCC?

LSCC has higher volatility (16.53%) compared to SUPN (10.31%). In terms of maximum drawdown, SUPN dropped -75.86% vs LSCC's -97.34%.

Which has better risk-adjusted returns?

LSCC currently has the higher Sharpe Ratio (4.41 vs 1.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.